•
Dec 31, 2022

Altria Q4 2022 Earnings Report

Altria's Q4 2022 results were reported, featuring an EPS increase and strategic investments in smoke-free products.

Key Takeaways

Altria reported a net revenue of $6.111 billion for Q4 2022, a decrease of 2.3% compared to Q4 2021. However, the adjusted diluted EPS increased by 8.3% to $1.18. The company also announced a new $1 billion share repurchase program and provided full-year earnings guidance for 2023.

Net revenues decreased by 2.3% to $6.1 billion, primarily driven by lower net revenues in the smokeable products segment.

Reported diluted EPS increased 70.5% to $1.50, primarily driven by favorable income tax items, 2021 Cronos-related special items, higher reported operating companies income (OCI), 2021 ABI-related special items, fewer shares outstanding and favorable interest expense, partially offset by 2022 changes in the estimated fair value of our investment in JUUL.

Adjusted diluted EPS increased 8.3% to $1.18, primarily driven by higher adjusted OCI, fewer shares outstanding and favorable interest expense.

A new $1 billion share repurchase program was authorized, expected to be completed by December 31, 2023.

Total Revenue
$5.08B
Previous year: $5.09B
-0.1%
EPS
$1.18
Previous year: $1.09
+8.3%
Marlboro Retail Share
42.2%
Previous year: 42.7%
-1.2%
Gross Profit
$3.51B
Previous year: $3.32B
+5.9%
Cash and Equivalents
$4.03B
Previous year: $4.54B
-11.3%
Free Cash Flow
$2.56B
Previous year: $2.6B
-1.3%
Total Assets
$37B
Previous year: $39.5B
-6.5%

Altria

Altria

Altria Revenue by Segment

Forward Guidance

Altria expects to deliver 2023 full-year adjusted diluted EPS in a range of $4.98 to $5.13, representing a growth rate of 3% to 6% from a base of $4.84 in 2022.

Positive Outlook

  • Continued smoke-free product research, development and regulatory preparation expenses
  • Enhancement of our digital consumer engagement system
  • Marketplace activities in support of our smoke-free products
  • Expect our 2023 full-year adjusted effective tax rate will be in a range of 24.5% to 25.5%
  • We also expect our 2023 capital expenditures to be between $175 million and $225 million and 2023 depreciation and amortization expenses of approximately $230 million.

Challenges Ahead

  • Conditions related to the economy, including the impact of high inflation, rising interest rates and global supply chain disruptions
  • ATC dynamics, including disposable income, purchasing patterns and adoption of smoke-free products
  • Regulatory and legislative developments
  • Lower expected net periodic benefit income due to market factors, including higher interest rates
  • Impact of the 2022 completion of the PMCC wind-down

Revenue & Expenses

Visualization of income flow from segment revenue to net income